PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.
Tuberculosis places a staggering burden on human health globally. The new World Health Organisation End-TB Strategy has highlighted the urgent need for more effective TB vaccines to improve control of the disease. Protein-based subunit vaccines offer potential as safe and effective generators of pro...
Main Authors: | Anneliese S Ashhurst, Thaigarajan Parumasivam, John Gar Yan Chan, Leon C W Lin, Manuela Flórido, Nicholas P West, Hak-Kim Chan, Warwick J Britton |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5858788?pdf=render |
Similar Items
-
CXCR6-Deficiency Improves the Control of Pulmonary Mycobacterium tuberculosis and Influenza Infection Independent of T-Lymphocyte Recruitment to the Lungs
by: Anneliese S. Ashhurst, et al.
Published: (2019-03-01) -
Enhancing immunogenicity of novel multistage subunit vaccine of Mycobacterium tuberculosis using PLGA:DDA hybrid nanoparticles and MPLA : subcutaneous administration
by: Farzad Khademi, et al.
Published: (2019-08-01) -
The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in mice.
by: Fan F Kao, et al.
Published: (2012-01-01) -
Humoral response to low molecular weight antigens of Mycobacterium tuberculosis by tuberculosis patients and contacts
by: Beck S.T., et al.
Published: (2005-01-01) -
Designing multiepitope subunit vaccine for Mycobacterium tuberculosis: Immunoinformatic approach
by: T. Senbadejo, et al.
Published: (2020-12-01)